Polycaprolactone-based in situ implant containing curcumin-PLGA nanoparticles prepared using the multivariate technique

References

• Anand P, Nair HB, Sung B, Kunnumakkara AB, Yadav VR, Tekmal RR, Aggarwal BB. 2009. Design of curcumin-loaded PLGA nanoparticles formulation with enhanced cellular uptake, and increased bioactivity in vitro and superior bioavailability in vivo. Biochem Pharmacol. 79:330–338.
   PubMed Web of Science ®Google Scholar
• Bilati U, Allémann E, Doelker E. 2003. Sonication parameters for the preparation of biodegradable nanocapsules of controlled size by the double emulsion method. Pharm Dev Technol. 8:1–9.
   PubMed Web of Science ®Google Scholar
• Chuah LH, Billa N, Roberts CJ, Burley JC, Manickam S. 2013. Curcumin-containing chitosan nanoparticles as a potential mucoadhesive delivery system to the colon. Pharm Dev Technol. 18:591–599.
   PubMed Web of Science ®Google Scholar
• Esmaeilzadeh-Gharedaghi E, Faramarzi MA, Amini MA, Rouholamini Najafabadi A, Rezayat SM, Amani A. 2012. Effects of processing parameters on particle size of ultrasound prepared chitosan nanoparticles: An Artificial Neural Networks Study. Pharm Dev Technol. 17:638–647.
   PubMed Web of Science ®Google Scholar
• Ferreira AP, Tobyn M. 2014. Multivariate analysis in the pharmaceutical industry: enabling process understanding and improvement in the PAT and QbD era. Pharm Dev Technol. 1–15.
   PubMed Web of Science ®Google Scholar
• Ferreira SL, Bruns RE, Ferreira HS, Matos GD, David JM, Brandao GC, et al. 2007. Box-Behnken design: An alternative for the optimization of analytical methods. Anal Chim Acta. 597:179–186.
   PubMed Web of Science ®Google Scholar
• Gao Y, Li Z, Sun M, Li H, Guo C, Cui J, et al. 2010. Preparation, characterization, pharmacokinetics, and tissue distribution of curcumin nanosuspension with TPGS as stabilizer. Drug Dev Ind Pharm. 36:1225–1234.
   PubMed Web of Science ®Google Scholar
• Gosangari S, Dyakonov T. 2013. Enhanced dissolution performance of curcumin with the use of supersaturatable formulations. Pharm Dev Technol. 18:475–480.
   PubMed Web of Science ®Google Scholar
• Gosangari SL, Watkin KL. 2012. Effect of preparation techniques on the properties of curcumin liposomes: Characterization of size, release and cytotoxicity on a squamous oral carcinoma cell line. Pharm Dev Technol. 17:103–109.
   PubMed Web of Science ®Google Scholar
• Guideline ICHHT. 2009. Pharmaceutical development. Q8 (2R). As revised in August.
   Google Scholar
• Jagani H, Kasinathan N, Meka SR, Josyula VR. 2015. Antiapoptotic Bcl-2 protein as a potential target for cancer therapy: A mini review. Artif Cells Nanomed Biotechnol. 24:1–10.
   Web of Science ®Google Scholar
• Jelvehgari M, Hassanzadeh D, Kiafar F, Loveym BD, Amiri S. 2011. Preparation and determination of drug-polymer interaction and in-vitro release of mefenamic acid microspheres made of celluloseacetate phthalate and/or ethylcellulose polymers. Iran Journal Pharm Res. 10:457–467.
   PubMed Web of Science ®Google Scholar
• Kasinathan N, Amirthalingam M, Reddy ND, Jagani HV, Volety SM, Rao JV. 2014a. In-situ implant containing PCL-curcumin nanoparticles developed using design of experiments. Drug Deliv. 23:1–9.
   PubMed Web of Science ®Google Scholar
• Kasinathan N, Jagani HV, Alex AT, Volety SM, Rao JV. 2014b. Strategies for drug delivery to the central nervous system by systemic route. Drug delivery. 1–15.
   Google Scholar
• Khalil NM, Nascimento TCFD, Casa DM, Dalmolin LF, Mattos ACD, Hoss I, et al. 2013. Pharmacokinetics of curcumin-loaded PLGA and PLGA–PEG blend nanoparticles after oral administration in rats. Colloids Surf B Biointerfaces. 101:353–360.
   PubMed Web of Science ®Google Scholar
• Koganti S, Jagani HV, Palanimuthu VR, Mathew JA, Rao MC, Rao JV. 2013. In vitro and in vivo evaluation of the efficacy of nanoformulation of siRNA as an adjuvant to improve the anticancer potential of cisplatin. Exp Mol Pathol. 94:137–147.
   PubMed Web of Science ®Google Scholar
• Yu LX. 2008. Pharmaceutical quality by design: product and process development, understanding, and control. Pharm Res. 25:781–791.
   PubMed Web of Science ®Google Scholar
• Leleux J, Williams RO. 2013. Recent advancements in mechanical reduction methods: particulate systems. Drug Dev Ind Pharm. 1–12.
   Web of Science ®Google Scholar
• Lionberger RA, Lee SL, Lee L, Raw A, Lawrence XY. 2008. Quality by design: concepts for ANDAs. AAPS J. 10:268–276.
   PubMed Web of Science ®Google Scholar
• Narayanan K, Subrahmanyam VM, Rao JV. 2014. Application of experimental design in preparation of nanoliposomes containing hyaluronidase. J Drug Deliv. 2014:948650.
   PubMedGoogle Scholar
• Packhaeuser CB, Schnieders J, Oster CG, Kissel T. 2004. In situ forming parenteral drug delivery systems: an overview. Eur J Pharm Biopharm. 58:445–455.
   PubMed Web of Science ®Google Scholar
• Pal S, Choudhuri T, Chattopadhyay S, Bhattacharya A, Datta GK, Das T, Sa G. 2001. Mechanisms of curcumin-induced apoptosis of Ehrlich's ascites carcinoma cells. Biochem Biophys Res Commun. 288:658–665.
   PubMed Web of Science ®Google Scholar
• Piñón-Segundo E, Nava-Arzaluz MG, Lechuga-Ballesteros D. 2012. Pharmaceutical Polymeric Nanoparticles Prepared by the Double Emulsion-Solvent Evaporation Technique. Recent Pat Drug Deliv Formul. 6:224–235.
   PubMedGoogle Scholar
• Ranjan AP, Mukerjee A, Helson L, Gupta R, Vishwanatha JK. 2013. Efficacy of liposomal curcumin in a human pancreatic tumor xenograft model: inhibition of tumor growth and angiogenesis. Anticancer Research. 33:3603–3609.
   PubMed Web of Science ®Google Scholar
• Ranjan AP, Mukerjee A, Helson L, Vishwanatha JK. 2012. Scale up, optimization and stability analysis of Curcumin C3 complex-loaded nanoparticles for cancer therapy. J Nanobiotechnology. 10:38.
   PubMed Web of Science ®Google Scholar
• Raveendran R, Bhuvaneshwar GS, Sharma CP. 2013. In vitro cytotoxicity and cellular uptake of curcumin-loaded Pluronic/Polycaprolactone micelles in colorectal adenocarcinoma cells. J Biomater Appl. 27:811–827.
   PubMed Web of Science ®Google Scholar
• Tabatabaei Mirakabad FS, Akbarzadeh A, Milani M, Zarghami N, Taheri-Anganeh M, Zeighamian V, et al. 2014. A Comparison between the cytotoxic effects of pure curcumin and curcumin-loaded PLGA-PEG nanoparticles on the MCF-7 human breast cancer cell line. Artif Cells Nanomed Biotechnol. 17:1–8.
   Google Scholar
• Yallapu MM, Jaggi M, Chauhan SC. 2012. Curcumin nanoformulations: a future nanomedicine for cancer. Drug Discov Today. 17:71–80.
   PubMed Web of Science ®Google Scholar